Next generation Bifidobacteria probiotics developed using CRISPR gene editing technology are one step closer after a new paper showed how select techniques could be applied in a programmable and strain-dependent manner.
As natural nutrition ingredient developer, Chr. Hansen, releases its new three-strain probiotic blend, we asked Adam Baker, Senior Manager of Human Health Innovation how the probiotic blend helps to support the health of preterm infants.